February 27, 2018 / 9:35 AM / 6 months ago

BRIEF-Biotest FY Revenue Falls To EUR 378.1 Mln On Recall Of Human Albumin

Feb 27 (Reuters) - BIOTEST AG:

* DGAP-ADHOC: BIOTEST AG: BIOTEST REACHES FY 2017 EBIT GUIDANCE

* FY REVENUE 378.1 MILLION EUR

* MAIN REASON FOR DECLINE IN REVENUE WAS RECALL OF HUMAN ALBUMIN

* FY EBIT GUIDANCE WAS REACHED WITH EUR 18 MILLION

* 2017 REVENUE OF EUR 378.1 MILLION IN CONTINUING OPERATIONS, COMPARED TO EUR 408.0 MILLION IN PREVIOUS YEAR​

* ONE-OFF EXPENSES IN AMOUNT OF EUR 37.7 MILLION HAD A NEGATIVE IMPACT ON EBIT OF CONTINUING OPERATIONS

* EBIT IN CONTINUING OPERATIONS AMOUNTED TO EUR -9.3 MILLION IN 2017 AFTER EUR 35.2 MILLION IN PREVIOUS YEAR Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below